or Try an Advanced Search...

    Technical Analysis for NRXP - NeuroRx, Inc.

    Grade Last Price % Change Price Change
    F 1.39 1.09% 0.02
    NRXP closed up 1.09 percent on Friday, November 1, 2024, on 22 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
    Earnings due: Nov 11
    *** please verify all earnings dates ***
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Up
    Historical NRXP trend table...
    Date Alert Name Type % Chg
    1,2,3 Retracement Bearish Bearish Swing Setup 0.00%
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
    Stochastic Reached Overbought Strength 0.00%
    Weak + Overbought Other 0.00%
    Inside Day Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Overbought Stochastic Strength 0.00%
    1,2,3 Retracement Bearish Bearish Swing Setup 1.09%
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 1.09%
    20 DMA Support Bullish 1.09%
    Older End-of-Day Signals for NRXP ...

       Recent Intraday Alerts

    Alert Time
    Up 1% about 20 hours ago
    Possible Inside Day about 20 hours ago
    Down 2 % about 23 hours ago
    Down 1% about 23 hours ago
    10 DMA Support 2 days ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    NRXP Chart by TradingView
    Basic chart:

    Profile

    NeuroRx, Inc. operates as a clinical stage-small molecule pharmaceutical company which develops novel therapeutics for the treatment of central nervous system disorders. Its drug candidate includes Cyclurad, an oral therapeutic for the treatment of acute/elevated suicidal ideation/crisis in bipolar depression. The company was incorporated in 2015 and is headquartered in Wilmington, Delaware.
    Classification
    Sector: Industrials
    Industry: Conglomerates
    Keywords: Life Sciences Health Sciences Health Care Central Nervous System Disorders Antidepressants Bipolar Disorder Treatment Of Central Nervous System Disorders Atypical Antipsychotics Bipolar Depression

    Is NRXP a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 5 bearish and 0 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 23 NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) and HOPE Therapeutics, Inc. Announce Participation at the ThinkEquity Conference October 30, 2024
    Oct 21 NRx started at buy by EF Hutton, cites suicide prevention focus
    Oct 12 NRx Pharmaceuticals Leadership Shift and Strategic Governance Decisions
    Oct 3 HOPE Therapeutics and NRx Pharmaceuticals acquires a West Coast psychiatric clinic
    Oct 3 HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announce Signing of a Letter of Intent to Acquire a Premier West Coast Interventional Psychiatric Clinic
    Sep 30 NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announces Completion of Twelve Months of Stability on the First Manufactured Commercial Scale Lot of NRX-100 (Ketamine)
    Sep 11 NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Featured on Psychiatrist.com
    Aug 26 HOPE Therapeutics Secures Financing For Ketamine Clinic Expansion
    Aug 15 NRx Pharmaceuticals, Inc. (NRXP) Q2 2024 Earnings Call Transcript
    Aug 14 NRx Pharmaceuticals (NASDAQ:NRXP) Reports Second Quarter and Year to Date 2024 Financial Results and Provides Business Update
    See more NRXP news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 7.333
    52 Week Low 1.1
    Average Volume 116,099
    200-Day Moving Average 3.07
    50-Day Moving Average 1.55
    20-Day Moving Average 1.31
    10-Day Moving Average 1.28
    Average True Range 0.11
    RSI (14) 49.24
    ADX 31.82
    +DI 17.79
    -DI 20.38
    Chandelier Exit (Long, 3 ATRs) 1.34
    Chandelier Exit (Short, 3 ATRs) 1.43
    Upper Bollinger Bands 1.51
    Lower Bollinger Band 1.12
    Percent B (%b) 0.68
    BandWidth 30.07
    MACD Line -0.07
    MACD Signal Line -0.10
    MACD Histogram 0.0335
    Fundamentals Value
    Market Cap 117.96 Million
    Num Shares 85.2 Million
    EPS -0.50
    Price-to-Earnings (P/E) Ratio -2.77
    Price-to-Sales 0.00
    Price-to-Book 6.95
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.49
    Resistance 3 (R3) 1.48 1.43 1.47
    Resistance 2 (R2) 1.43 1.41 1.44 1.46
    Resistance 1 (R1) 1.41 1.39 1.42 1.42 1.46
    Pivot Point 1.37 1.37 1.37 1.37 1.37
    Support 1 (S1) 1.34 1.34 1.35 1.35 1.31
    Support 2 (S2) 1.30 1.32 1.30 1.31
    Support 3 (S3) 1.27 1.30 1.30
    Support 4 (S4) 1.28